Center for innovative neurotech advancement - cinta

Active Cooperative Agreement Awarded Last action

Award ID
U54EB033650
Recipient
Awarding agency
Obligated
$62,027,613

Award facts

Completion date 85% complete
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Place of performance
Boston, MA 02114, USA

Award details come from USAspending.gov.

Description

Abstract
Overall we propose to create the center for innovative neurotech advancement (cinta), a new center for rapid transformation of emerging technologies into commercially viable, clinically focused solutions for disorders of the nervous system. The PD/PIS, DRS. Steven schachter and paolo bonato, together have many decades of experience creating and managing complex multi-institutions, multi-disciplinary, national translational research organizations, and expertise in neurotechnology-related research, and will leverage their experience to further innovate, adapt, and deploy the well-developed, proven approach to needs-driven healthcare technology innovation pioneered, developed, and validated for 23 years by the consortia for improving medicine with innovation & technology (cimit). Led for the past 23 years by DR. Schachter and colleagues, cimit has a proven track record of success as a national center for healthcare innovation and a unique model to identify unmet medical needs; find, fund, and facilitate technology-based projects to solve those needs; and rapidly move these innovations from concept to manufacturing to commercialization to the end-user. Combining their decades-long expertise and interest in neurological disorders and rehabilitation, the PD/PIS will oversee the advancement of projects under cinta's five cores: administrative core, outreach core, evaluation core, innovator subprojects core, and resource subawards core. Paul tessier, program director for the administrative core, will have overall responsibility for integrating the activities of the different cores to accomplish the overall goals of the proposed center under the guidance of the center PD/PIS. The administrative core will ensure ongoing input from NIH program directors and science officers, as well as input from the steering committee members who are integral in providing guidance to the program to help diversify the types of projects as well as increase representation of proposers of varying backgrounds. Key center activities to accomplish the overall goals include established needs assessment and project solicitation processes, and cimit's virtual collaboration platform, colab, to help cinta investigators and facilitators track important deliverables in four areas critical to commercial success. Colab will also be used as a platform for shared cinta resources, such as a cinta website with access to resources available to key stakeholders. Finally, cinta will draw upon the well-established national and international collaboration networks of cimit and spaulding to achieve cinta's goals and enhance externally funded collaborations.

Transactions

Action Obligated Date
Amendment $368,500
Amendment $0
Amendment $716,090
Amendment $91,896
Amendment $1,481,027
Amendment $103,997
Amendment $1,236,539
Amendment $1,473,250
Amendment $1,484,778
Amendment $104,145
Amendment $1,536,867
Amendment $104,078
Amendment $1,327,859
Amendment $1,413,780
Amendment $104,107
Amendment Center for innovative neurotech advancement - cinta transition funding $1,000,000
Amendment $1,200,000
Amendment $1,133,544
Amendment $1,180,087
Amendment $1,419,143
Amendment $683,070
Amendment $1,472,965
Amendment $1,021,224
Amendment $1,201,485
Amendment $1,149,277
Amendment $773,617
Amendment $1,000,000
Amendment $0
Amendment $0
Amendment Center for innovative neurotech advancement - cinta (17041 stanford) $0
Amendment $0
Amendment $2,940,899
Amendment $1,026,799
Amendment $1,329,031
Amendment $1,225,748
Amendment $1,000,000
Amendment $1,000,000
Amendment $1,208,978
Amendment $1,208,978
Amendment $1,208,978
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $2,594,105
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
Motif Neurotech, Inc. 1. Objective The goal of this project is to advance the development of a minimally invasive implant and supporting system for the treatment of… $553,098
Neurava Inc. Source Information 04 - Research Plan V2.docx (shared with NIH in Spring 2025) Principal Investigators: Jay Shah, PhD Institution: Neurava Inc. Project Title: A… $562,910
The Johns Hopkins University YEAR 1 Milestone 1: Design Freeze (After Phase 1 Analysis w/ External Manufacturer); (11 Months after award of contract) Milestone 2: Pre-Clinical Data… $768,027
Coolspine, LLC Year 1 of this project proposal seeks to advance our Intrathecal Cooling Catheter System by completing the following milestones: Milestone 1: FDA Strategy and… $920,644
Neurologic Solutions Inc. Y1M1 - Quality - Implement Full QMS. This includes reviewing all components of the quality system and implementing all relevant components necessary for a… $181,820
The Washington University The Research Plan has been revised from the initial submission, based on the programmatic discussions with Michael Koeris, Paul Byunghoon Yoo, and Julia… $1,881,778
The Johns Hopkins University To address these clinical needs, we propose a wearable ultrasound (US) and photoacoustic (PA) monitoring (WUPM) technology to identify the at-risk fetus and… $742,248
The Leland Stanford Junior University Our POC translational goal is to precisely control the electrical activity of hundreds of RGCs, with single-cell and cell-type specificity, in an acute test… $1,666,728
University Of California, LOS Angeles A. SIGNIFICANCE In the United States, more than 2 million individuals 12 years and older meet criteria for an opioid use disorder (OUD).[1] In the past year,… $811,424
National Collegiate Inventors & Innovators Alliance, Inc. VentureWell proposes to support CIMIT’s new center for rapid transformation of emerging technologies into commercially viable, clinically focused… $11,566,921
University Of Arizona 1. Develop theranostic handheld applicator integrating ultrasound imaging and therapy and test ergonomics of device with end users (Years 1�3) a. To… $1,844,338
Neurastasis, Inc. The overall project goal to reach design freeze and complete the requisite testing in preparation for a first-in-human trial is subdivided into three… $1,638,503
Biomotum, Inc. BPMT Milestones for Biomotum Year 1: Define user needs, product requirements and build initial prototypes 1. Need Statement: 25 families and 25 PTs complete… $1,641,125
National Collegiate Inventors & Innovators Alliance, Inc. VentureWell proposes to support CIMIT's new center for rapid transformation of emerging technologies into commercially viable, clinically focused solutions… $1,696,551
The Spaulding Rehabilitation Hospital Corporation Dr Paolo Bonato (Spaulding Rehabilitation Hospital) will work closely with Dr Steven C Schachter (CIMIT) on all aspects of the activities proposed in the… $375,229
Show all 15

Quick answers

Who received award U54EB033650?

U54EB033650 was awarded to The General Hospital Corporation by National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health) on September 30, 2022.

How much is award U54EB033650 worth?

$62,027,613 has been obligated on U54EB033650.

Which agency awarded U54EB033650?

National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health) awarded U54EB033650, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award